Arcus Biosciences Inc (RCUS) — Cash Flow Quality Index

Latest as of December 2021: -0.22x

Arcus Biosciences Inc (RCUS) has a Cash Flow Quality Index of -0.22x as of December 2021. Operating cash flow of $-62.10 Million is below net income of $279.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Arcus Biosciences Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.22x
Operating CF / Net Income

Operating Cash Flow

$-62.10 Million
USD

Net Income

$279.37 Million
USD

Data as of

Dec 2021
Most recent filing

Arcus Biosciences Inc Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Arcus Biosciences Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Arcus Biosciences Inc generate cash.

Annual Cash Flow Quality Index for Arcus Biosciences Inc (2021–2021)

Year-by-year earnings quality comparison for Arcus Biosciences Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -4.85x $-256.17 Million $52.83 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.